Sanofi (SNY) Cash from Discontinued Operations (2019 - 2025)

Sanofi has disclosed Cash from Discontinued Operations across 6 years of filings, most recently posting -$4.6 billion for Q4 2025.

• In Q4 2025, Cash from Discontinued Operations changed N/A year-over-year to -$4.6 billion; the TTM figure through Dec 2025 stood at -$4.1 billion (changed N/A YoY), while the FY2025 annual figure was -$4.1 billion, down 19.09% from the prior year.
• Cash from Discontinued Operations came in at -$4.6 billion for Q4 2025 at Sanofi, down from $218.6 million in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of $10.7 billion in Q4 2022 to a low of -$4.6 billion in Q4 2025.
• Average Cash from Discontinued Operations over 4 years is $2.1 billion, with a median of $170.1 million recorded in 2024.
• The largest YoY upside for Cash from Discontinued Operations was 33.68% in 2025 against a maximum downside of 93.69% in 2025.
• Over 4 years, Cash from Discontinued Operations stood at $10.7 billion in 2022, then decreased by 7.11% to $10.0 billion in 2023, then plunged by 99.46% to $53.8 million in 2024, then plunged by 8559.38% to -$4.6 billion in 2025.
• Per Business Quant data, the three most recent Cash from Discontinued Operations figures were -$4.6 billion in Q4 2025, $218.6 million in Q3 2025, and $3.4 million in Q2 2025.